IL-17 has been implicated in various autoimmune diseases such as rheumatoid arthritis, psoriasis, and multiple sclerosis. In these conditions, the overproduction of IL-17 contributes to chronic inflammation and tissue damage. Histologically, this is evident through the persistent presence of inflammatory cells, increased vascularity, and tissue fibrosis.
